Brought to you by 
Dainippon and Sumitomo Pharmaceuticals plan 2005 merger
03 Jan 2005
Executive Summary
Dainippon Pharmaceutical and Sumitomo Pharmaceuticals (SP) have signed a basic agreement to merge in October 2005, a move that will place the combined company among the top 10 Japanese pharma firms, with anticipated annual sales of $2.67bn (Y280bn) by 2008.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Dainippon and Sumitomo Pharmaceuticals plan 2005 merger
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice